A new wave of mobile apps that help track exposure to the coronavirus is coming to U.S. states ahead of the holidays as public health officials bet that recently introduced features from Apple Inc. and Alphabet Inc.’s Google will significantly boost adoption and impact.

Inovio Pharmaceuticals Inc. received clearance from the U.S. health regulatory agency to begin a mid-stage study of the company’s Covid-19 vaccine candidate, the vaccine maker said.

Germany-based CureVac NV published detailed interim Phase I data of the company’s Covid-19 vaccine candidate CVnCoV.

The U.S. Food and Drug Administration approved Kala Pharmaceuticals’ Eysuvis for the short-term treatment of dry eye disease. 

Outcome Health announced the launch of Who Saves Me?, a campaign to bring awareness to the overwhelming percentage of physicians who quietly suffer from burnout and mental health struggles. 

Andrea Bastek – Director of Innovation at Florence, the largest eISF + Remote Site Access platform in clinical research – discusses three ways in which sponsors and CROs can increase compliance with a purpose-built, site-centric, remote access platform.

Becton Dickinson and Co. reached a $60 million settlement with the attorneys general of 48 U.S. states and Washington D.C., resolving allegations the company concealed the risks of now-discontinued pelvic mesh devices.

After attending several virtual scientific conferences since the start of the COVID-19 lockdown, TBWA\WorldHealth explores which practices should stay, which ones will need to come back, and how pharmaceutical brands can stand out in this medium.

The U.S. National Institutes of Health (NIH) awarded seven companies and academic institutions grants to develop digital health technology to help with the Covid-19 pandemic.

World leaders came together virtually to mark the 75th anniversary of the United Nations, as the deadly coronavirus pandemic and tensions between the United States and China challenge the effectiveness and solidarity of the 193-member body.